Parallel to its response as an acute phase reactant, hypoalbuminemia in COVID-19 may reflect a dysregulated immune response in the early stages of the disease, which could lead to increased capillary permeability and the release of albumin into the interstitium. This evidence concerns the gene ALB and Hypoalbuminemia.